Content |
Education
Alexander Andryushechkin received a diploma of higher education from Omsk State University named after Dostoevsky and a master's degree from Omsk State University named after Dostoevsky.
Career
2016
In 2016, Alexander Andryushechkin began working at Generium-Nekst LLC, and before that he was the head of the financial department of the Alcoholic Siberian Group.
2022: Appointment as CEO of MedInvest Group
In early March 2022, MedInvest Group announced the appointment of Alexander Andryushechkin as the new general director of the group of companies instead of Igor Simonovsky. Before heading MedInvest Group, Andryushechkin held a similar position at Generium Nekst.
MedInvest Group does not comment on the reasons for the personnel changes, and also does not report who, instead of Alexander Andryushechkin, headed Generium-Nekst.
By March, 2022 MedInvestGrupp Group unites 25 centers of nuclear medicine PAT-Technology and several centers of radiation therapy in 25 regions of Russia, network of multidisciplinary clinics "To +31", the author's project of the academician Konstantin Lyadov - "Lyadov's Clinics", Gamma Clinic medical center in Obninsk and two productions of radiopharmaceuticals. In addition, at the end of 2021, the group entered the market of Kazakhstan, opening the PET-Technologies center in Almaty for 340 million rubles. [1]
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |